CLDN3 and ovarian carcinoma: (124) first reported that CLDN3 and CLDN4 are consistently overexpressed across all major subtypes of epithelial ovarian cancer, while being either absent or expressed at very low levels in benign cystadenomas and normal ovarian tissues.